ASC to Present Unique Technology at LSE 2021 | ASC

ASC will be attending at LSE life science tradeshow (virtual) on February 2021 in Texas

LIVE!

February 3, 2021 | 11:00AM - 1:30PM CT

Register | Agenda

Texas Medical Center

University of Texas - All Campuses

University of Texas Health - All Campuses

Drop by to get more information on these topics.

• Special Promo! Mouse Model Generation with CRISPR/Cas9

• iPSC & Stem Cell research Service & products

• Grant application & GEMM design consultation

See you there!

About Applied StemCell, Inc.

Applied StemCell, Inc. (ASC) is a fast-growing Gene & Cell Therapy CRO headquartered in California, USA. ASC was founded in 2008 with a goal to advance gene-editing and stem cell innovation for biomedical research and the biotechnology industry. With more than 12 years of experience in genome editing and stem cell technologies, ASC is proud to develop innovative technology platforms offering services and products in the field of Stem Cells (iPSCs/ESCs, differentiated cells) and animal/cell models for disease modeling, antibody discovery & screening, bioproduction, AAV potency assays, cell therapy and regenerative medicine. Our Cell and Gene Therapy Bioservice platform also includes consultation for Pre-IND filing and CMC processes.

More information can be found at www.appliedstemcell.com.

Media Contact:

Maki Ogawa

Marketing Director, Applied StemCell, Inc.

408-773-8007

maki.ogawa@appliedstemcell.com